TLIS - TALIS ALERT: Bragar Eagel & Squire P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (NASDAQ:TLIS) on behalf of long-term stockholders following a class action complaint that was filed against Talis on March 8, 2022 with a Class Period relating to stock purchases made pursuant to the Company's February 2021 IPO. Our investigation concerns whether the board of directors of Talis have breached their fiduciary duties to the company.
The complaint filed alleges that the Registration Statement was false and misleading and omitted to state material adverse facts. Specifically, Defendants failed ...